Share price
₹23 latest close · −8.2% over the last 90 sessions
₹23 month-end · −11.1% over 12 months
₹23 month-end · −24.0% over 3 years
₹23 month-end · +31.8% since Apr '21
52-week range ₹20.00 to ₹29.68 · 1-year volatility 33.9%
Was the rally earned?
Mostly the multiple.
- Most of the fall came from investors paying a lower multiple (P/E 35.0x to 31.1x); per-share earnings added 0 points.
- The share count barely moved.
Mostly the multiple.
- Most of the fall came from investors paying a lower multiple (P/E 40.9x to 31.1x); per-share earnings added 0 points.
- The share count barely moved.
Partly.
- Most of the rise came from investors paying a higher multiple (P/E 22.8x to 31.1x); per-share earnings added 0 points.
- The share count barely moved.
What do "pts" mean?
"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.
Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.
Net profit is trailing twelve months as reported with a 60-day lag.
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-59.9% (2021-05 peak to 2021-08 low, recovered 2022-01)
-51.4% (2023-08 peak to 2026-03 low, not yet recovered)
-50.7% (2022-01 peak to 2023-04 low, recovered 2023-07)
Is it expensive against its own past and its peers?
Usual range 27.7x to 43.6x since 2021-04.
72% above the Process Industries median.
The chart loads when you open this tab.
The chart loads when you open this tab.
How to read this
Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).
Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.
Where does it rank among Process Industries peers?
Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- Revenue growth27th▼ 4 pts vs a year ago
- EPS growth39th▼ 9 pts vs a year ago
- Debt/equity ↓6thflat vs a year ago
- Cash cycle ↓40th▲ 4 pts vs a year ago
- P/E ↓26th▼ 3 pts vs a year ago
- 12M momentum46th▼ 20 pts vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Process Industries sector page Watch it move against Process Industries in the Observatory
What is the price implying?
At a P/E of 28.5x, the price would imply about 19.4%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Earnings figures have not updated recently, so the company is left out of the lists.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Process Industries The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹23.00
- P/E
- 31.1x
- Market Cap
- ₹40 cr
- Revenue (TTM)
- ₹98 cr
- P/S
- 0.4x
- P/B
- 1.1x
- ROE
- 3.5%
- Debt / Equity
- 1.7x
- Promoter Holding
- 43.4%
- 12M Momentum
- -11.1%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance75%Beyond threshold
Other income as a share of pre-tax profit (trailing twelve months): 74.7%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion—Not enough data
Not enough reported data to compute this.
Free cash flow—Not enough data
Not enough reported data to compute this.
Receivable days vs history0 daysWithin range
Debtor days are below the median of the previous three fiscal years by 0 days (28 vs 28). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress26% of fixed assetsWithin range
Capital work-in-progress is 26% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days0 days / 2 yrsWithin range
Days payable changed by 0 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 2 years, promoters trimmed 1.5 pts.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like AMBICA AGARBATHIES & AROMA IND today on valuation, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −21% to +39% vs the market, against −6% for all non-financial companies in the same months.
- The gap against the base rate (+0.5%, 80% range −5.8% to +28.7%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 6 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 34 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| HISARMETAL Non-Energy Minerals |
Jun 2025 | 33x | 9% | 0% | −12% | −21% |
| RELCHEMQ Process Industries |
May 2025 | 57x | 7% | −5% | −21% | −38% |
| BALPHARMA Health Technology |
Nov 2023 | 66x | 10% | +23% | −4% | −11% |
| REMSONSIND Producer Manufacturing |
Aug 2022 | 23x | 12% | +7% | −14% | +76% |
| BVCL Non-Energy Minerals |
May 2022 | 23x | 6% | +4% | −21% | +40% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| AROGRANITE Non-Energy Minerals |
Jul 2024 | 44x | 5% | +43% | −5% | −36% |
| SALONA Process Industries |
Jul 2025 | 44x | 7% | −15% | −20% | −10% |
| ROML Process Industries |
Feb 2023 | 52x | 15% | −1% | −33% | −30% |
How reliable is this?
Matched on P/E, P/S, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, P/S and drawdown from 12-month high. Not used (unavailable for this company): ROCE and operating margin. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What changed?
9 events since Aug '21
- MarPriceFell 51% from the Aug 2023 peak to the Mar 2026 low.
- JunPeer rankSlipped to the 3rd quartile of Process Industries on EPS growth (from the 2nd quartile).
- JanValuationP/E crossed above the 90th percentile of its own history to date (47.9x).
- JulPriceRegained the 2022-01 peak, 3 months after the low.
- JunValuationP/E crossed above the 90th percentile of its own history to date (50.9x).
- JunPeer rankMoved into the 2nd quartile of Process Industries on EPS growth (from the 3rd quartile).
- AprPriceFell 51% from the Jan 2022 peak to the Apr 2023 low.
- JanPriceRegained the 2021-05 peak, 5 months after the low.
Show 1 earlier event
- AugPriceFell 60% from the May 2021 peak to the Aug 2021 low.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history68 months · 2021-04 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | Debt / Equity |
|---|---|---|---|---|
| 2026-11 | 31.1x | ₹98 cr | 3.5% | 1.7x |
| 2026-10 | 31.0x | ₹98 cr | 3.5% | 1.7x |
| 2026-09 | 33.0x | ₹98 cr | 3.5% | 1.7x |
| 2026-08 | 32.8x | ₹98 cr | 3.5% | 1.7x |
| 2026-07 | 33.8x | ₹98 cr | 3.5% | 1.7x |
| 2026-06 | 34.2x | ₹98 cr | 3.5% | 1.7x |
| 2026-05 | 32.8x | ₹98 cr | 3.5% | 1.7x |
| 2026-04 | 32.1x | ₹98 cr | 3.5% | 1.7x |
| 2026-03 | 27.8x | ₹98 cr | 3.5% | 1.7x |
| 2026-02 | 34.3x | ₹98 cr | 3.5% | 1.7x |
| 2026-01 | 31.9x | ₹98 cr | 3.5% | 1.7x |
| 2025-12 | 34.6x | ₹98 cr | 3.5% | 1.7x |
| 2025-11 | 35.0x | ₹98 cr | 3.5% | 1.7x |
| 2025-10 | 34.2x | ₹98 cr | 3.5% | 1.7x |
| 2025-09 | 34.6x | ₹98 cr | 3.5% | 1.7x |
| 2025-08 | 35.8x | ₹98 cr | 3.5% | 1.7x |
| 2025-07 | 36.5x | ₹98 cr | 3.5% | 1.7x |
| 2025-06 | 39.3x | ₹98 cr | 3.5% | 1.7x |
| 2025-05 | 41.5x | ₹98 cr | 3.5% | 1.7x |
| 2025-04 | 36.2x | ₹98 cr | 3.5% | 1.7x |
| 2025-03 | 36.3x | ₹98 cr | 3.5% | 1.7x |
| 2025-02 | 35.0x | ₹98 cr | 3.5% | 1.7x |
| 2025-01 | 39.5x | ₹98 cr | 3.5% | 1.7x |
| 2024-12 | 43.6x | ₹98 cr | 3.5% | 1.7x |
| 2024-11 | 40.1x | ₹98 cr | 3.5% | 1.7x |
| 2024-10 | 36.1x | ₹98 cr | 3.5% | 1.7x |
| 2024-09 | 39.9x | ₹98 cr | 3.5% | 1.7x |
| 2024-08 | 43.7x | ₹98 cr | 3.5% | 1.7x |
| 2024-07 | 36.4x | ₹98 cr | 3.5% | 1.7x |
| 2024-06 | 34.8x | ₹98 cr | 3.5% | 1.7x |
| 2024-05 | 36.5x | ₹98 cr | 3.5% | 1.7x |
| 2024-04 | 40.8x | ₹98 cr | 3.5% | 1.7x |
| 2024-03 | 35.5x | ₹98 cr | 3.5% | 1.7x |
| 2024-02 | 43.0x | ₹98 cr | 3.5% | 1.7x |
| 2024-01 | 47.9x | ₹98 cr | 3.5% | 1.7x |
| 2023-12 | 40.5x | ₹98 cr | 3.5% | 1.7x |
| 2023-11 | 40.9x | ₹98 cr | 3.5% | 1.7x |
| 2023-10 | 43.4x | ₹98 cr | 3.5% | 1.7x |
| 2023-09 | 44.0x | ₹98 cr | 3.5% | 1.7x |
| 2023-08 | 53.6x | ₹98 cr | 3.5% | 1.7x |
| 2023-07 | 47.4x | ₹98 cr | 3.5% | 1.7x |
| 2023-06 | 50.9x | ₹98 cr | 3.5% | 1.7x |
| 2023-05 | 33.9x | ₹98 cr | 3.5% | 1.7x |
| 2023-04 | 30.3x | ₹98 cr | 3.5% | 1.7x |
| 2023-03 | 27.4x | ₹98 cr | 3.5% | 1.7x |
| 2023-02 | 31.1x | ₹98 cr | 3.5% | 1.7x |
| 2023-01 | 32.9x | ₹98 cr | 3.5% | 1.7x |
| 2022-12 | 33.2x | ₹98 cr | 3.5% | 1.7x |
| 2022-11 | 38.7x | ₹98 cr | 3.5% | 1.7x |
| 2022-10 | 41.7x | ₹98 cr | 3.5% | 1.7x |
| 2022-09 | 42.9x | ₹98 cr | 3.5% | 1.7x |
| 2022-08 | 43.0x | ₹98 cr | 3.5% | 1.7x |
| 2022-07 | 34.9x | ₹98 cr | 3.5% | 1.7x |
| 2022-06 | 30.4x | ₹98 cr | 3.5% | 1.7x |
| 2022-05 | 31.4x | ₹98 cr | 3.5% | 1.7x |
| 2022-04 | 36.9x | ₹98 cr | 3.5% | 1.7x |
| 2022-03 | 35.7x | ₹98 cr | 3.5% | 1.7x |
| 2022-02 | 38.1x | ₹98 cr | 3.5% | 1.7x |
| 2022-01 | 48.6x | ₹98 cr | 3.5% | 1.7x |
| 2021-12 | 28.9x | ₹98 cr | 3.5% | 1.7x |
| 2021-11 | 22.8x | ₹98 cr | 3.5% | 1.7x |
| 2021-10 | 24.4x | ₹98 cr | 3.5% | 1.7x |
| 2021-09 | 23.3x | ₹98 cr | 3.5% | 1.7x |
| 2021-08 | 22.0x | ₹98 cr | 3.5% | 1.7x |
| 2021-07 | 24.3x | ₹98 cr | 3.5% | 1.7x |
| 2021-06 | 30.3x | ₹98 cr | 3.5% | 1.7x |
| 2021-05 | 33.9x | ₹98 cr | 3.5% | 1.7x |
| 2021-04 | 23.6x | ₹98 cr | 3.5% | 1.7x |